News Focus
News Focus
icon url

DewDiligence

11/10/11 12:19 PM

#130741 RE: acgood #130740

The third phase-2 trial—the one that wasn’t ready for reporting in today’s PR—tests Lipitor ± REGN727 for 12 weeks with a safety follow-up at 20 weeks (http://www.clinicaltrials.gov/ct2/show/NCT01288443 ).